Skip to main content

Front Row Advisors LLC

SEC CIK
0001729254
Latest filing
Aug 13, 2026

ALLO holding history

Allogene Therapeutics, Inc. in every 13F filed by Front Row Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALLO overviewAll 13F holders of ALLOFull Q2 2026 holdings

Shares (Q1 2022)
0
Sold out in Q1 2022
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q4 2021
Holdings of ALLO by Front Row Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20220$00.0%−1,000−100.0%Sold outHolders
Q4 20211,000$15.0K<0.1%+1,000NewHolders